Librería: RUSH HOUR BUSINESS, Worcester, MA, Estados Unidos de America
EUR 72,11
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Pages are clean with no markings.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 139,41
Cantidad disponible: 8 disponibles
Añadir al carritoCondición: new.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 153,91
Cantidad disponible: 8 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 156,07
Cantidad disponible: 8 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 152,27
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 150,81
Cantidad disponible: 8 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 155,02
Cantidad disponible: 8 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Original o primera edición
EUR 183,07
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
EUR 176,08
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 336.
Idioma: Inglés
Publicado por John Wiley and Sons Inc, US, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
EUR 183,90
Cantidad disponible: 4 disponibles
Añadir al carritoHardback. Condición: New. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
Librería: Chiron Media, Wallingford, Reino Unido
EUR 172,35
Cantidad disponible: 8 disponibles
Añadir al carritoHardcover. Condición: New.
EUR 187,12
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 616.
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 172,33
Cantidad disponible: 8 disponibles
Añadir al carritoHardback. Condición: New. New copy - Usually dispatched within 4 working days.
EUR 192,20
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 336.
EUR 188,58
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Num Pages: 616 pages, illustrations. BIC Classification: MMG; PN; TDCW. Category: (P) Professional & Vocational. Dimension: 241 x 156 x 39. Weight in Grams: 996. . 2014. Hardback. . . . .
EUR 208,58
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 616.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 221,73
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 596 pages. 9.50x6.50x1.50 inches. In Stock.
Idioma: Inglés
Publicado por John Wiley and Sons Inc, US, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Librería: Rarewaves.com UK, London, Reino Unido
EUR 173,18
Cantidad disponible: 4 disponibles
Añadir al carritoHardback. Condición: New. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
EUR 240,46
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Num Pages: 616 pages, illustrations. BIC Classification: MMG; PN; TDCW. Category: (P) Professional & Vocational. Dimension: 241 x 156 x 39. Weight in Grams: 996. . 2014. Hardback. . . . . Books ship from the US and Ireland.
Idioma: Inglés
Publicado por John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Librería: AussieBookSeller, Truganina, VIC, Australia
Original o primera edición
EUR 268,17
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 227,70
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. Neuware - This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward.The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 179,46
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 1029.
Idioma: Inglés
Publicado por John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Librería: CitiRetail, Stevenage, Reino Unido
Original o primera edición Impresión bajo demanda
EUR 162,98
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 203,04
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 596 pages. 9.50x6.50x1.50 inches. In Stock. This item is printed on demand.